CASI Kacepetan wutah bathi saben saham ing taun lumaku CASI Pharmaceuticals, Inc

Simbol resmi perusahaan casipharmaceuticals.com (CASI)

CASI Pharmaceuticals is scaling the treatment of hematological pathologies through partnerships with global biolabs to expand in China. However, trade disputes between the US and China could limit the export of innovations. This linear chart of EPS year-over-year comparisons on GURU.Markets contains data where the current figure is 0.00. Stable management is successfully adapting the drug portfolio for government procurement.

CASI - Wutah bathi ing taun lumaku CASI Pharmaceuticals, Inc ing rentang 04.07.2022 - 14.03.2026

Rincian analitis lan laporan data perusahaan casipharmaceuticals.com (CASI)

- nilai saham lan prakiraan konsensus rega:
Rega bursa CASI Pharmaceuticals, Inc.|CASI - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar CASI Pharmaceuticals, Inc|CASI - Nilai Perusahaan
- data ekuitas miturut neraca:
Ekuitas saben Saham CASI Pharmaceuticals|CASI - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih casipharmaceuticals.com|CASI - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Total Utang marang Modal CASI Pharmaceuticals|CASI - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal CASI Pharmaceuticals, Inc.|CASI - Gunggung utang perusahaan|Utang-utang marang aset resik CASI Pharmaceuticals, Inc|CASI - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan CASI Pharmaceuticals|Rasio likuiditas kritis casipharmaceuticals.com
- statistik bathi lan rasio pasar:
CASI - Bathi resik|Penghasilan resik sing dikarepake CASI Pharmaceuticals|CASI - Pangali P/E|Pangali Forward P/E CASI Pharmaceuticals, Inc.|CASI - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan CASI Pharmaceuticals, Inc|CASI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan CASI Pharmaceuticals|CASI - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan casipharmaceuticals.com|CASI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep CASI Pharmaceuticals
Pambiji fundamental:CASI - CASI Pharmaceuticals, Inc
Produk asil prodhuksi CASI Pharmaceuticals, Inc

This indicator measures the dynamics of net earnings per share by calculating the percentage deviation of the current value from the same period last year. By analyzing the annual EPS growth rate on the GURU.Markets platform, an investor assesses the efficiency of capital generation. The metric identifies profitability trends stripped of market noise. For CASI Pharmaceuticals (CASI), this figure is critical due to pressure from new cell therapy methods. Stable EPS growth confirms the competitiveness of the company's patents in oncohematology.

Pesaing wigati

Kacepetan wutah bathi saben saham ing taun lumaku TG Therapeutics Inc (TGTX)|Wutah bathi saben saham ing taun lumaku Arcellx Corp|Kacepetan wutah bathi saben saham ing taun lumaku Disc Medicine Pharma IRON|Wutah bathi ing taun lumaku SNDX|kuraoncology.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku ADCT (ADC Therapeutics SA)|FHTX - Wutah bathi resik saben saham ing taun iki|Vor Bio - Wutah bathi ing taun lumaku|NKTX - Wutah bathi ing taun lumaku|coeptistx.com (COEP) - Wutah bathi saben saham ing taun lumaku|ATNM - Prakiraan wutah bathi resik saben saham ing taun iki|ESLA (Estrella Immunopharma, Inc.) - Wutah bathi ing taun lumaku|Marker Bio (MRKR) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki INAB (IN8bio, Inc)|ERNA (eternatx.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku GT Biopharma, Inc. GTBP|APTO (Aptose Biosciences Inc) - Dinamika bathi saben saham ing taun lumaku|Bio-Path Holdings, Inc. - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku MEIP (MEI Pharma Inc)|VINC: Wutah bathi ing taun lumaku